Aspire Biopharma Holdings, Inc. (ASBP) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 28.35K | 4.26K | 1.94K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 22.6K | 5.26K | 1.06K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 79.72% | 123.47% | 54.46% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 5.75K | -1K | 884 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 20.28% | -23.47% | 45.54% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 1.65M | 1.85M | 1.15M | 799.89K | 15.56M | 640.51K | 215.26K | 501.01K | 2.52M | 402.62K | 324.74K | 288.25K | 324.56K | 314.03K | 255.26K | 297.84K | 109.22K | 55 | 15.31K | 2.38K |
| OpEx % of Revenue | 5826.26% | 43380.05% | 59061.36% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.36M | 1.75M | 938.48K | 447K | 15.29M | 565.79K | 630.77K | 501.01K | 2.52M | 402.62K | 255.26K | 288.25K | 324.56K | 314.03K | 255.26K | 297.84K | 109.22K | 2.37K | 15.31K | 2.38K |
| SG&A % of Revenue | 4779.73% | 41032.36% | 48350.44% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 296.72K | 100.03K | 207.9K | 352.89K | 263.09K | 116.36K | 7K | 10.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | 1046.53% | 2347.69% | 10710.92% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -41.64K | -422.52K | -10.5K | 0 | 0 | 69.48K | 0 | 0 | 0 | 0 | 0 | 0 | -2.32K | 0 | 0 |
| Operating Income | -1.65M | -1.85M | -1.15M | -799.89K | -15.56M | -640.51K | -215.26K | -501K | -2.52M | -403K | -325K | -288K | -325K | -314K | -255K | -298K | -109K | -3.07K | -15.31K | -2.38K |
| Operating Margin % | -5805.98% | -43403.52% | -59015.82% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 89.42% | -188.74% | -432.16% | -59.66% | -516.59% | -58.94% | 33.77% | -73.96% | -676.31% | -28.34% | -27.45% | 3.36% | -198.17% | -10124.68% | -1565.58% | -12405.25% | -1310.09% | - | - | - |
| EBITDA | -1.65M | -1.85M | 875.71K | -1.45M | -15.65M | -8.64M | -631K | -394.06K | -2.28M | -553 | -258 | 246 | -435 | 2.23M | 257 | -160 | 219 | 0 | 0 | -2.38K |
| EBITDA Margin % | -5805.98% | -43403.52% | 45116.54% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 89.48% | 78.59% | 238.78% | -268.83% | -585.32% | -1562051.54% | -244473.64% | -160287.8% | -524910.34% | -100.02% | -200.39% | 253.75% | -298.63% | - | - | 93.29% | 7400% | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 2.02M | 0 | 0 | 0 | 0 | 106.94K | 0 | 402.45K | 324.74K | 288.25K | 324.56K | 0 | 255.26K | 297.84K | 109.22K | 3.07K | 15.31K | 0 |
| EBIT | -1.65M | -1.85M | -370.44K | -1.45M | -15.65M | -8.64M | -215.26K | -394.07K | -2.28M | -142K | -325K | -288K | 2.87M | 2.23M | -255K | -298K | -109K | 0 | -15.31K | -2.38K |
| Net Interest Income | -1.59M | -6.23M | -1.48M | -527.89K | -289.93K | -424.47K | 76.75K | -38.27K | 51.54K | 251.7K | 255.48K | 2.1M | 3.2M | 2.54M | 1.33M | 418.53K | 21.39K | 0 | 0 | 0 |
| Interest Income | 5.01K | 0 | 0 | 0 | 0 | 67.17K | 76.75K | 169.91K | 234.85K | 260.67K | 255.48K | 2.1M | 3.2M | 2.54M | 1.33M | 418.53K | 21.39K | 0 | 0 | 0 |
| Interest Expense | 1.6M | 6.23M | 1.48M | 527.89K | 289.93K | 491.63K | 0 | 208.18K | 183.31K | 8.97K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -1.58M | -2.86M | -705K | -1.18M | -384.85K | -97.99K | 93.75K | -101K | 55.58K | 251.7K | 255.48K | 2.1M | 3.2M | 2.54M | 1.33M | 418.53K | 21.39K | 0 | 0 | 0 |
| Pretax Income | -3.22M | -4.71M | -1.85M | -1.98M | -15.94M | -738.5K | -537K | -602K | -2.47M | -151K | -69.26K | 1.81M | 2.87M | 2.23M | 1.08M | 120.69K | -87.83K | -55 | -15.31K | -2.38K |
| Pretax Margin % | -11367.02% | -110484.25% | -95337.09% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | -1.01K | 1.01K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.07K | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0.14% | -0.19% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 5583.64% | 0% | 0% |
| Net Income | -3.22M | -4.71M | -1.85M | -1.98M | -15.94M | -8.93M | -537K | -602K | -2.47M | -151K | -69.26K | 1.81M | 2.87M | 2.23M | 1.08M | 120.69K | -87.83K | -755 | -15.31K | -2.38K |
| Net Margin % | -11367.02% | -110484.25% | -95337.09% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 79.78% | 47.29% | -244.6% | -229.12% | -546.18% | -5814.57% | -675.36% | -133.22% | -185.9% | -106.77% | -106.43% | 1401.33% | 3370.1% | 295464.24% | 7134.62% | 5164.75% | -1036.61% | - | - | - |
| Net Income (Continuing) | -3.22M | -4.71M | -1.85M | -1.98M | -15.94M | -11.97M | -216.27K | -602K | -2.47M | -151K | -69.26K | 1.81M | 2.87M | 2.23M | 1.08M | 120.69K | -87.83K | -755 | -15.31K | -2.38K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.16 | -3.15 | -1.49 | -1.61 | -16.83 | -12.94 | -0.78 | -0.87 | -3.58 | -0.24 | -0.11 | 2.28 | 3.20 | 2.48 | 1.20 | 0.13 | -0.19 | -0.00 | -0.02 | -0.00 |
| EPS Growth % | 87.17% | 75.66% | -91.03% | -85.06% | -370.11% | -5291.67% | -609.09% | -138.16% | -211.88% | -109.68% | -109.17% | 1653.85% | 1784.21% | - | 7158.82% | - | - | - | - | - |
| EPS (Basic) | -2.16 | -3.15 | -1.49 | -1.61 | -16.83 | -12.94 | -0.78 | -0.87 | -3.58 | -0.24 | -0.11 | 2.28 | 3.20 | 2.48 | 1.20 | 0.13 | -0.19 | -0.00 | -0.02 | -0.00 |
| Diluted Shares Outstanding | 1.49M | 1.49M | 1.24M | 1.23M | 947.25K | 690.04K | 690.04K | 690.03K | 689.99K | 636.63K | 636.63K | 793.78K | 898.44K | 898.44K | 898.44K | 898.44K | 467.19K | 682.81K | 898.44K | 781.25K |
| Basic Shares Outstanding | 1.49M | 1.49M | 1.24M | 1.23M | 947.25K | 690.04K | 690.04K | 690.03K | 689.99K | 636.63K | 636.63K | 793.78K | 898.44K | 898.44K | 898.44K | 898.44K | 467.19K | 682.81K | 898.44K | 781.25K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |